vimarsana.com

Latest Breaking News On - Chromatographic immunoassay - Page 1 : vimarsana.com

Global Respiratory Syncytial Virus Diagnostics Market Expected to Reach $1 95 Billion by 2030 with a 9 7% CAGR

Growing Neonatal Population and Supportive Healthcare

Global HBsAg Testing Market to Grow at a Robust CAGR During

RSV Diagnostics Market Size Estimated to Reach $1 3 Billion by 2026

RSV Diagnostics Market Segment Analysis – By Geography The RSV Diagnostics Market based on Geography can be further segmented into North America (U.S., Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand and Rest of Asia-Pacific), South America(Brazil, Argentina and others), and RoW (Middle East and Africa). North America held the largest share in 2020 with 37.2% of overall market. The growth in this segment is owing to the factors such as increasing number of strategic partnerships among the pharmaceutical companies and in vitro diagnostic manufacturing companies, rising incidences of RSV infections and an increasing infant population. The growing innovations in new technologies such as filament-based antibody detection assays, thin layer-based amperometric enzyme immunoassay (EIA), and multiplex virus testing in the region is propelling the growth of the market. Asia-Pacif

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.